12 withdrawn. 12 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Withdrawn 12 |
| Phase 1 | 2 | Withdrawn 2 |
| Phase 3 | 2 | Withdrawn 2 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias fostamatinib - Immune Mediated Anemia, Immune Mediated Thrombocytopenia | Phase 2 | Withdrawn | National Heart, Lung, and Blood Institute (NHLBI) | 2025-11-07 | 2025-11-10 | |
| Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy Belumosudil - Chronic Graft Versus Host Disease | Phase 2 | Withdrawn | Kadmon, a Sanofi Company | 2025-06-16 | 2026-02-12 | |
| Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis Magnesium Sulfate - Bronchiolitis, Viral | Phase 2 / Phase 3 | Withdrawn | University of Louisville | 2021-07-21 | 2026-05-11 | |
| Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS) Assigned Interventions - Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2020-06-30 | 2023-05-06 | |
| Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy Microcannula Harvest Adipose, Centricyte 1000, IV Sterile Normal Saline - BPH, Nocturia | Phase 1 / Phase 2 | Withdrawn | Robert W. Alexander, MD, FICS | 2019-11-01 | 2021-01-12 | |
| Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments Nitazoxanide, Placebo (for Nitazoxanide) - Bronchiolitis | Phase 2 | Withdrawn | Telethon Kids Institute | 2016-12-01 | 2017-10-12 | |
| Treating Wheezing in Children With Hypertonic Saline (TWICS) hypertonic saline, saline - Wheeze | Phase 2 | Withdrawn | Dr. Michael Flavin | 2013-10-01 | 2015-11-13 | |
| Impact Of A Health Care Protocol For Patients Suffering Symptoms Of Mild Acute Viral Bronchiolitis On Early Release In The Emergency Department Randomization early depart - Bronchiolitis | Phase 2 | Withdrawn | Laval University | 2011-10-01 | 2015-09-07 | |
| Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury Autologous cord blood - Traumatic Brain Injury | Phase 1 / Phase 2 | Withdrawn | Charles Cox | 2011-01-01 | 2015-12-10 | |
| Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis BIBW 2948 BS - Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic | Phase 2 | Withdrawn | Boehringer Ingelheim | 2008-08-01 | 2014-03-27 | |
| Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL Dasatinib - Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Withdrawn | Bristol-Myers Squibb | 2006-12-01 | 2016-02-17 | |
| A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease LBH589, Methylprednisolone - Chronic Graft-Versus-Host Disease | Phase 2 | Withdrawn | SCRI Development Innovations, LLC | 2013-02-13 |
Bronchiolitis Obliterans Syndrome (7) · Bronchiolitis (3) · Asthma (1) · Brain Injuries, Traumatic (1) · Bronchiolitis, Viral (1) · Bronchitis, Chronic (1) · Graft vs Host Disease (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Nocturia (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Prostatism (1) · Prostatitis (1) · Pulmonary Disease, Chronic Obstructive (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Respiratory Sounds (1)
Bronchial Diseases (12) · Lung Diseases (12) · Lung Diseases, Obstructive (12) · Respiratory Tract Diseases (12) · Bronchiolitis (8) · Immune System Diseases (8) · Bronchiolitis Obliterans (7) · Organizing Pneumonia (7) · Graft vs Host Disease (6) · Infections (5) · Pathological Conditions, Signs and Symptoms (5) · Respiratory Tract Infections (5) · Pathologic Processes (3) · Signs and Symptoms (3)
Dasatinib (1) · KD025 (1) · Magnesium Sulfate (1) · Methylprednisolone (1) · Methylprednisolone Acetate (1) · Mycophenolic Acid (1) · Panobinostat (1) · Prednisone (1) · Saline Solution, Hypertonic (1) · Sirolimus (1) · Sodium Chloride (1) · Tacrolimus (1) · belumosudil (1) · fostamatinib (1) · nitazoxanide (1)
Boehringer Ingelheim (1) · Bristol-Myers Squibb (1) · Charles Cox (1) · Dr. Michael Flavin (1) · Kadmon, a Sanofi Company (1) · Laval University (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Robert W. Alexander, MD, FICS (1) · SCRI Development Innovations, LLC (1) · Telethon Kids Institute (1) · University of Louisville (1) · University of Maryland, Baltimore (1)
United States (6) · Australia (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · United Kingdom (1)
Aldo T Iacono, MD (1) · Charles S Cox, Jr., MD (1) · Daniel R Couriel, M.D. (1) · Jamie Y Hur, D.O. (1) · John W Berkenbosch, MD (1) · Michael Flavin (1)